"GRIN Therapeutics begins Phase III trial of radiprodil for NDD" was originally created and published by Clinical Trials ...

GRIN Therapeutics begins patient dosing in global phase 3 Beeline trial of investigational radiprodil for GRINRelated neurodevelopmental disorder: New York Monday, January 12, 202 ...

GRIN Therapeutics, Inc., a leader in the development of targeted disease-specific therapies for serious neurodevelopmental disorders, today announced that it has dosed the first patient in its global ...

GRIN-related neurodevelopmental disorder (GRIN-NDD) is a family of rare, genetically defined neurodevelopmental disorders caused by mutations in GRIN genes and abnormal activity of the ...

The EU regulator has approved FibroGen and Astellas Evrenzo for adults with anaemia caused by chronic kidney disease (CKD), just days after the FDA turned down the drug in the US. The decision makes ...

Global pulmonary function testing market growth is driven by rising prevalence of chronic respiratory diseases, increasing geriatric population, and growing adoption of diagnostic monitoring ...

Novel research led by Brazilian scientists describes the immune system's reactions in detail in the first living patient to receive a genetically modified pig kidney transplant. This paves the way for ...

Score had temporal stability for patients with stable kidney function, but was responsive for only some with worsening disease.

Background The relationship of social determinants of health (SDOH), environmental exposures and medical history to lung function trajectories is underexplored. A better understanding of these ...

This recognition of the best forex brokers for 2026 represents an independent assessment based on publicly available ...

Explore the latest high-frequency economic indicators, with rising yields, strong consumer spending, and commodity trends shaping a positive outlook.

A lucky lottery player in Arkansas won a $1.8 billion Powerball jackpot on Christmas Eve, but the winning ticket holder still hasn’t come forward to claim their prize. CNN’s Rafael Romo spoke with a ...